Two-Stage Culture Method for Type I NKT Cell Amplification
Solution Overview
Problem
Current methods for amplifying NKT cells in vitro are not specific enough to fully exploit the advantages of type I NKT cells, particularly in anti-tumor and anti-infective applications, as they do not effectively enhance their killing activity and cytokine secretion.
Innovation Solution
A two-stage culture method using α-GalCer as a specific stimulant and cytokines IL-2, IL-7, IL-15, and IL-12 at different stages to amplify and differentiate type I NKT cells, with α-GalCer-loaded CD1d-expressing dendritic cells stimulating continuous proliferation and cytokine addition guiding directed differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional NKT cell amplification methods are used, then some NKT cells can be amplified, but the amplification is not specific enough to fully exploit the advantages of type I NKT cells
Solution Approach 1:
The amplification process is divided into two distinct culture stages: first stage focuses on specific amplification of type I NKT cells using α-GalCer stimulation, while the second stage performs synchronous amplification and guided differentiation. This segmentation allows each stage to optimize for specific objectives, ensuring high specificity for type I NKT cell amplification while maintaining functional characteristics.
Solution Approach 2:
The method dynamically adjusts culture parameters including cytokine combinations (IL-2, IL-7, IL-15, IL-12), stimulant concentrations (α-GalCer), and culture duration at different stages. By changing these parameters between stages, the method achieves specific amplification of type I NKT cells with enhanced killing activity and cytokine secretion, resolving the contradiction between quantity and specificity.
2Quantity of substance
If type I NKT cells are amplified without directed differentiation, then the number of cells increases, but their killing activity and effector cytokine secretion are not enhanced
Solution Approach 1:
The method performs preliminary amplification in the first culture stage using α-GalCer-loaded CD1d-expressing cells and cytokines IL-2 and IL-7 to establish a robust population of type I NKT cells. Then in the second stage, preliminary differentiation guidance is introduced with IL-15 and IL-12 before the final differentiation phase, ensuring that cells are pre-prepared for effective differentiation while maintaining high numbers.
Solution Approach 2:
The method maintains continuous stimulation with α-GalCer-loaded CD1d-expressing cells throughout both culture stages, ensuring uninterrupted proliferation and functional maturation. The continuous presence of the specific stimulant combined with staged cytokine addition ensures that amplification and differentiation occur simultaneously, preserving both cell number and functional capability.
3Reliability
If a complex multi-stage differentiation protocol is used, then functional characteristics are improved, but the procedure becomes more complex
Solution Approach 1:
The differentiation protocol is segmented into two clear culture stages with distinct objectives: first stage for specific amplification and second stage for synchronous amplification and guided differentiation. Each stage has defined cytokine combinations and duration, making the complex differentiation process manageable and reproducible while maintaining functional characteristics.
Solution Approach 2:
The method uses systematic parameter changes between stages - adding IL-15 and IL-12 in the second stage while maintaining α-GalCer stimulation, and adjusting cytokine concentrations according to stage requirements. This structured parameter adjustment achieves functional maturation without creating procedural complexity, as each change has a clear purpose and timing.
Data Source
AI summary
The present invention relates to a method for inducing amplification of human type I NKT cells in vitro using a “specific stimulant+staged cytokine” mode, which consists of two culture stages, wherein the first culture stage focuses on specific amplification of the number of the type I NKT cells, in which a specific stimulant α-GalCer is used to advantageously amplify the type I NKT cells and α-GalCer-loaded CD1d-expressing cells are used to stimulate continuous proliferation of the type I NKT cells while adding cytokines IL-2 and IL-7 to assist growth of the type I NKT cells; and the second culture stage is to synchronously perform amplification of the number of the type I NKT cells and guide directed function differentiation, in which CD1d-expressing cells incubated with α-GalCer continue to stimulate proliferation of the type I NKT cells while adding IL-2, IL-7 and IL-15 to assist amplification of the type I NKT cells and guide differentiation, and IL-12 is added to the culture system 1-2 days before the end of culture to guide further directed differentiation of the type I NKT cells and enhance their killing activity. The method of the present invention is simple to operate, can greatly amplify the type I NKT cells in vitro while improving the killing activity of the amplification products, and is suitable for large-scale production.